Evaluation of Acinetobacter baumannii, Klebsiella pneumoniae, and Staphylococcus aureus respiratory tract superinfections among patients with COVID-19 at a tertiary-care hospital in Tehran, Iran
Authors:
- Maryam Mobarak-QamsariMMMaryam Mobarak-Qamsari
- Bita JenaghiBJBita Jenaghi
- Leyla SahebiLSLeyla Sahebi
- Mahsa Norouzi-ShadehiMNMahsa Norouzi-Shadehi
- Mohammad-Reza SalehiMSMohammad-Reza Salehi
- Abbas Shakoori-FarahaniASAbbas Shakoori-Farahani
- Hoda KhoshnevisHKHoda Khoshnevis
- Alireza AbdollahiAAAlireza Abdollahi
- Mohammad-Mehdi FeizabadiMFMohammad-Mehdi Feizabadi
Open Access
- 2 September 2023
- journal article
- research article
- Published by Springer Nature in European Journal of Medical Research
- Vol. 28 (1) , 1-11
Abstract
Background: The emergence of healthcare-associated infections (HAIs) or superinfections in COVID-19 patients has resulted in poor prognosis and increased mortality. Methods: In a cross-sectional study, 101 respiratory samples were collected from ICU-admitted COVID-19 patients. The HAI rate, demographics, and antibiotic resistance were assessed. Results: The HAI rate was 83.16% (76.62% bacterial and 6.54% fungal). The prevalence of 3 major HAI-causing organisms included Klebsiella pneumoniae (41.5%), Acinetobacter baumannii (20.8%), and Staphylococcus aureus (4.9%). Mortality and intubation ventilation proportions of 90% (p = 0.027) and 92.2% (p = 0.02) were significant among patients with superinfection, respectively. Multiple logistic regression analysis showed SpO2 pressure (odds ratio 0.842; 95% CI 0.750–0.945; p = 0.004) as a predictive factor in the association between antibiotic usage and mortality. More than 50% of patients received carbapenems. The resistance rates to at least one antibiotic of third-generation cephalosporins, aminoglycosides, quinolones/fluoroquinolones, tetracyclines, and β-lactam inhibitors were 95.2%, 95.2%, 90%, 57.1%, and 100% among A. baumannii isolates and 71.4%, 55%, 69%, 61.9%, and 59.5% among K. pneumoniae isolates, respectively. A proportion of 60% was recorded for methicillin-resistant S. aureus isolates. Conclusion: As a result, antibiotic treatment should be administered following the microbial resistance profile. Contact isolation and infection control measures should be implemented as needed.Keywords
This publication has 44 references indexed in Scilit:
- Panton-Valentine Leukocidin–Secreting Staphylococcus aureus Pneumonia Complicating COVID-19Emerging Infectious Diseases, 2020
- Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysisInternational Journal of Infectious Diseases, 2020
- The proximal origin of SARS-CoV-2Nature Medicine, 2020
- Phenotypic and Molecular Characterization ofβ-Lactamases among Enterobacterial Uropathogens in Southeastern NigeriaCanadian Journal of Infectious Diseases and Medical Microbiology, 2020
- Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial InfectionsAdvanced Science, 2019
- Molecular Mechanisms of Colistin Resistance Among Pandrug-Resistant Isolates of Acinetobacter baumannii with High Case-Fatality Rate in Intensive Care Unit PatientsMicrobial Drug Resistance, 2018
- Analysis of Culture-Dependent versus Culture-Independent Techniques for Identification of Bacteria in Clinically Obtained Bronchoalveolar Lavage FluidJournal of Clinical Microbiology, 2014
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Optimal Sampling Sites and Methods for Detection of Pathogens Possibly Causing Community-Acquired Lower Respiratory Tract InfectionsJournal of Clinical Microbiology, 2009
- CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care settingAmerican Journal of Infection Control, 2008